<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 21 Apr 2026 06:40:37 -0400--><rss version="2.0">
    <channel>
        <title>Evommune, Inc. (EVMN) SEC Filings</title>
        <link>https://ir.evommune.com/financial-information/sec-filings/rss</link>
        <description>Evommune, Inc. (EVMN) - SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_2094dba4d31887f5c3cda4773c265127/evommune/files/theme/images/logo-sm.png</url>
                <title>Evommune, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0002092017-26-000003/0002092017-26-000003.pdf</link>
                <pubDate>Fri, 17 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0002092017-26-000003/0002092017-26-000003.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0002091053-26-000003/0002091053-26-000003.pdf</link>
                <pubDate>Fri, 17 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0002091053-26-000003/0002091053-26-000003.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0001678620-26-000003/0001678620-26-000003.pdf</link>
                <pubDate>Fri, 17 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0001678620-26-000003/0001678620-26-000003.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0001757072-26-000003/0001757072-26-000003.pdf</link>
                <pubDate>Fri, 17 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0001757072-26-000003/0001757072-26-000003.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0001742496-26-000003/0001742496-26-000003.pdf</link>
                <pubDate>Fri, 17 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0001742496-26-000003/0001742496-26-000003.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0001620548-26-000003/0001620548-26-000003.pdf</link>
                <pubDate>Fri, 17 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0001620548-26-000003/0001620548-26-000003.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[S-1 - General form for registration of securities under the Securities Act of 1933]]></title>
                <description><![CDATA[4 Related Documents: S-1, EX-5.1, EX-23.1, EX-FILING FEES]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-161516/0001193125-26-161516.pdf</link>
                <pubDate>Fri, 17 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-161516/0001193125-26-161516.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-152864/0001193125-26-152864.pdf</link>
                <pubDate>Mon, 13 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-152864/0001193125-26-152864.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[S-8 - Securities to be offered to employees in employee benefit plans]]></title>
                <description><![CDATA[4 Related Documents: S-8, EX-5.1, EX-23.1, EX-FILING FEES]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-093978/0001193125-26-093978.pdf</link>
                <pubDate>Thu, 05 Mar 26 00:00:00 -0500</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-093978/0001193125-26-093978.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[9 Related Documents: 10-K, EX-4.3, EX-19.1, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-97]]></description>
                <link>https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-093932/0001193125-26-093932.pdf</link>
                <pubDate>Thu, 05 Mar 26 00:00:00 -0500</pubDate>
                <guid>https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-093932/0001193125-26-093932.pdf</guid>
                                                                            </item>
            </channel>
</rss>